Nachrichten zur Eli Lilly & Co. Aktie

Big Money Exits: Iconic Pharma Stock Sold by High-Profile Asset Manager

Key PointsSold 6,430 shares of Eli Lilly and Company; estimated transaction value ~$4.78 millionPost-trade holding: 61,292 shares valued at $46.77…

3 Things Investors Need to Know Ahead of Eli Lillys Q3 Earnings Report

The rapid growth rates of recent years arent guaranteed to continue.…

Eli Lilly Q3 earnings eyed for insights into drug pricing policies

Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely…

Eli Lilly Q3 earnings eyed for insights into drug pricing policies, obesity and diabetes drug performance

Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely…

Investment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing

Key PointsIncreased position by 259,392 shares in Q3 2025; estimated $193.03 million trade based on the average price during Q3…

Novo, Lilly Fall as Trump Touts ‘Much Lower’ Ozempic Price

Novo Nordisk and Eli Lilly shares fell after President Donald Trump said the price of the blockbuster diabetes drug Ozempic could come down to just…

Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s

Eli Lilly and Novo Nordisk shares dropped after President Donald Trump said he wants a $150 price tag for GLP-1s.…

Why Eli Lilly (LLY) Stock Is Down Today

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty…

NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs

Trumps pledge to slash GLP-1 drug prices sends Novo Nordisk and Eli Lilly shares tumbling, raising questions about the feasibility…

Trump says Ozempic will get cheaper. Novo Nordisk, Eli Lilly stock slump

Trump’s comments on Ozempic “signal aggressive posturing” in drug price negotiations, an analyst said…

American Express, Truist Financial and Fifth Third rise premarket; Eli Lilly falls By Investing.com

American Express, Truist Financial and Fifth Third rise premarket; Eli Lilly falls…

Cantor Fitzgerald maintains Eli Lilly stock rating despite orforglipron setback By Investing.com

Cantor Fitzgerald maintains Eli Lilly stock rating despite orforglipron setback…

Treasuries Rally Amid Credit Woes; Trump to Meet Zelenskiy, Putin | Bloomberg Brief 10/17/2025

US equity futures decline, Treasuries extend rally and the dollar stays on track for its biggest weekly drop since July.…

Novo Nordisk, Eli Lilly shares drop as Trump promises lower weight loss drug prices

Shares of Novo Nordisk (NYSE:NVO) and Eli Lilly and Co (NYSE:LLY), two major pharmaceutical companies that produce weight-loss drugs, dropped…

Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? @themotleyfool #stocks $LLY $GS $NVO $VKTX

These stocks have climbed in the triple digits over the past few years.…

Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out Fat-Loss Drugs

Shares of Eli Lilly and Novo Nordisk move lower in Thursdays after-hours session after President Trump indicated weight-loss drugs are…

Chesapeake Sells 9,900 Eli Lilly (LLY) Shares Worth $7.7 Million

Key PointsChesapeake sold 9,875 Eli Lilly and Company shares; estimated trade value of approximately $7.68 million, based on the average…

Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly? @themotleyfool #stocks $VKTX $LLY

The smaller drugmaker is looking to disrupt a fast-growing market.…

Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know

Eli Lilly (LLY) concluded the recent trading session at $826.57, signifying a +1.75% move from its prior days close.…

Eli Lilly: Outstanding Orforglipron Data Reinforces Value Proposition

…

The Zacks Analyst Blog Highlights Apple, Eli Lilly and Visa

Strong sector performers stand out as AAPL, LLY, and V gain traction through services, drug demand, and digital payment growth.…

Top Stock Reports for Apple, Eli Lilly & Visa

Apples strong Services growth, Eli Lillys GLP-1 momentum, and Visas digital expansion headline todays top stock reports.…

Eli Lilly: The Rally Has More Room To Run (Rating Upgrade)

…

Down 44%, Should You Buy the Dip on Viking Therapeutics? @themotleyfool #stocks $VKTX $LLY $PFE $NVO $MTSR

The company is readying to take on pharma giants Novo Nordisk and Eli Lilly.…

Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly

Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after…

Exclusive: Bill Gates, PAHO consider ways to bring weight-loss drugs to lower-income countries

The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo…

Eli Lilly (LLY) Gains As Market Dips: What You Should Know

Eli Lilly (LLY) reached $855.35 at the closing of the latest trading day, reflecting a +1.14% change compared to its…

Lilly Endowment sells $137 million in Eli Lilly shares By Investing.com

Lilly Endowment sells $137 million in Eli Lilly shares…

Where Will LLY Be in 5 Years?

After nearly two years of sideways price action, Eli Lilly stock could soar to new highs between now and 2030.…

Eli Lilly to invest more than $1B in India, Reuters reports

Eli Lilly (LLY) plans to invest more than $1B in India in the coming years to boost manufacturing and supply…

Eli Lilly Stock Rises 16% in a Week: Heres What You Should Know

LLY shares have jumped 16% last week as Pfizers landmark government deal boosted investor confidence across the pharma sector.…

Eli Lilly: Beyond Weight Loss

Eli Lilly is riding a big trend.…

Eli Lilly to invest over $1 billion in India to expand manufacturing capacity

Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through…

Eli Lilly (LLY) Laps the Stock Market: Heres Why

Eli Lilly (LLY) closed the most recent trading day at $839.87, moving +2.44% from the previous trading session.…

Eli Lilly (LLY) Laps the Stock Market: Heres Why

Eli Lilly (LLY) closed the most recent trading day at $839.87, moving +2.44% from the previous trading session.…

Why Shares of Eli Lilly Soared This Week

Pfizers deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs.…

Hims & Hers Health (HIMS) Legal Relief Raises Fresh Questions About Its Long-Term Regulatory Risks

In the past week, a U.S. federal judge dismissed Eli Lillys lawsuit against Willow Health, a telehealth competitor to Hims…

Eli Lilly and Its Competitors Pop on the Pfizer News

Market Analysis by covering: Eli Lilly and Company, Merck & Company Inc, Pfizer Inc, AbbVie Inc. Read s Market…

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy…

Insight: Trump administration targets deals in dozens of industries before midterms

Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its…

Stock Market Today: Nike, Eli Lily surge; Robinhood slips

Here are the stocks that made the biggest moves today.…

Eli Lilly, Merck Lead Market Cap Stock Movers on Wednesday By Investing.com

Eli Lilly, Merck Lead Market Cap Stock Movers on Wednesday…

Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More

Pharmaceutical stocks gained Wednesday afternoon amid anticipation Pfizers deal with the Trump administration could lead to more with other firms.…

Buy HIMS Stock At $56?

Earlier this year, Eli Lilly had initiated a lawsuit against Willow Health along with three other telehealth companies concerning the…

Eli Lilly: Strong Buy On Sustained Growth, Expanding Moat, And Pipeline Depth

…

Are These GLP-1 Trial Results About to Send Eli Lillys Stock Soaring?

The pharmaceutical company had a clinical setback earlier this year, but thats now in the rearview mirror.…

LLY Gets EU Approval for Alzheimers Drug & FDA Nod to Cancer Therapy

Eli Lilly secures EU approval for Alzheimers drug Kisunla and gains FDA nod to breast cancer therapy Inluriyo.…

Eli Lilly: Buying The Dip With Confidence

…

Stock Movers: Eli Lilly, CarMax, Jabil

Bloomberg journalists discuss todays biggest winners and losers in the stock market. Listen for analysis on the companies making news…

LLY vs. NVO: Which Obesity Drug Stock Is the Better Buy Now?

Eli Lillys diversified pipeline, rapid tirzepatide growth and rising estimates give it the edge over Novo Nordisk in the obesity…